Over the past two decades, Canadians’ use of opioid analgesics has substantially grown, making the nation the second-largest user of opioid analgesics
How can people with opioid use disorder get better virtual care?
Virtual care is the new normal around the globe. The emergence of COVID-19 introduced a dual public health emergency in British Columbia. The province
Improving opioid agonist care continuation, meta-analysis
Improving opioid agonist care continuation remains to be a challenge for many community based addiction treatment organizations. Research into
Educational studies: What can Medical Trainees learn in an Inner-City Hospital?
Gaps in addiction medicine training are a reason for poor substance use care in North America.
Boost for Oral Opioid Agonist Therapy
Although opioid agonist treatment is effective in treating opioid use disorders, retention in such treatment is suboptimal in part due to quality of
America could relax opioid treatment access policies
Canada and the United States (U.S.) face an opioid use disorder and opioid overdose epidemic. The most effective OUD treatment is opioid agonist
Do more drug tests improve addiction treatment?
Frequent drug tests in addiction treatment have become a common practice despite proven benefits of such testing. When do tests become the end instead
Updating alcohol Cochrane literature review
Updating Cochrane systematic reviews makes them most useful and fresh for readers. We updated our review on concurrent alcohol and drug problems
Frequent urine testing lacks evidence
Clinicians commonly use urine drug tests to detect or validate self-reported drug use, particularly when beginning and maintaining opioid agonist